Abstract
The patient was an 86-year-old female who suffered from advanced non-small cell-lung cancer (cT4N3M1, Stage IV). She was treated with combined chemotherapy of gemcitabine and S-1 as first-line therapy. This regimen was performed as a phase I trial for elderly patients with advanced non-small cell lung cancer. The treatment assessment was evaluated as partial response. No toxic events were observed due to this therapy, so she was treated as an outpatient. She was considered to have good quality of life.
MeSH terms
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / diagnostic imaging
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Drug Combinations
-
Female
-
Gemcitabine
-
Humans
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / drug therapy*
-
Oxonic Acid / therapeutic use*
-
Positron-Emission Tomography
-
Tegafur / therapeutic use*
-
Tomography, X-Ray Computed
Substances
-
Drug Combinations
-
Deoxycytidine
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
Gemcitabine